Hydroxocobalamin 相關新聞
Hydroxocobalamin 目前有 0 則相關新聞報導,預測適應症 20 個。
本頁整合 Hydroxocobalamin 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Treatment of known or suspected cyanide poisoning. Cyanokit is to be administered together with appropriate decontamination and supportive measures.
- 證據等級:L5
- 預測適應症(20 個):
- esophageal varices without bleeding(99.2%)
- esophageal varices with bleeding(99.2%)
- varicose disease(98.9%)
- immune-mediated necrotizing myopathy(98.7%)
- antisynthetase syndrome(98.6%)
- focal myositis(98.6%)
- inflammatory myopathy with abundant macrophages(98.5%)
- idiopathic eosinophilic myositis(98.5%)
- vitamin deficiency disorder(98.4%)
- congenital prothrombin deficiency(98.3%)
- biotin metabolic disease(98.1%)
- osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome(97.2%)
- C1 inhibitor deficiency(96.9%)
- maternally-inherited mitochondrial myopathy(96.7%)
- vitamin B12 deficiency(96.7%)
- maternally-inherited mitochondrial dystonia(96.6%)
- primary optic atrophy(96.5%)
- hypophosphatasia(96.5%)
- serpinopathy with toxic serpin polymerization(96.3%)
- Steel syndrome(96.0%)
相關新聞(0 則)
目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。